Financial statements Nova-Pharma
Balance sheet of Nova-Pharma
Company age:
Age:
13 y. 8 m. 19 d.
Share capital:
Share capital:
5 000 PLN
Balance sheet data of NOVA-PHARMA
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
|---|---|---|---|---|---|
| Total assets | 975 118,58 | 1 090 942,72 | 777 552,73 | 775 411,17 | 792 253,81 |
| A. Fixed assets | - | 0,00 | 0,00 | 0,00 | 0,00 |
| B. Current assets | 975 118,58 | 1 090 942,72 | 777 552,73 | 775 411,17 | 792 253,81 |
| C. Share capital contributions (basic funds) | - | - | 0,00 | 0,00 | - |
| D. Own shares (stocks) | - | - | 0,00 | 0,00 | - |
| Total liabilities | 975 118,58 | 1 090 942,72 | 777 552,73 | 775 411,17 | 792 253,81 |
| A. Equity | -160 027,90 | -103 350,48 | -102 132,74 | -128 067,41 | -128 723,93 |
| B. Liabilities and provisions for liabilities | 1 135 146,48 | 1 194 293,20 | 879 685,47 | 903 478,58 | 920 977,74 |
| I. Long-term liabilities | - | - | - | - | - |
| II. Short-term liabilities | - | - | - | - | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.